Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Evogene Ltd (NYSE:EVGN)

6.38
Delayed Data
As of Sep 30
 +0.08 / +1.27%
Today’s Change
5.93
Today|||52-Week Range
9.32
-20.75%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close6.30
Today’s open6.27
Day’s range6.26 - 6.39
Volume3,230
Average volume (3 months)3,968
Market cap$160.4M
Dividend yield--
Data as of 3:07pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-17.24%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-23.31%
P/E ratio--
Price/Sales18.24
Price/Book1.54

Competitors

 Today’s
change
Today’s
% change
OSIROsiris Therapeutics ...+0.26+5.53%
ENZYEnzymotec Ltd+0.04+0.57%
ADVMAdverum Biotechnolog...+0.10+2.49%
AXSMAxsome Therapeutics ...+0.19+2.47%
Data as of 4:00pm ET, 09/30/2016

Financials

Next reporting dateNovember 16, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$11.1M
Annual profit (last year)-$17.2M
Net profit margin-154.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Tel Aviv

Forecasts

Search for Jobs